NFKB1 and type 1 diabetes mellitus: Preclinical research highlights its ability to significantly lower blood glucose levels in animal models, primarily through the actions of key compounds like W. somnifera, which modulates critical pathways such as Nrf2/NFκB signaling in type 1 diabetes models [126,129].